All AbMole products are for research use only, cannot be used for human consumption.
BTRX-335140 is a selective and orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively. Navacaprant endows with favorable in vitro ADMET and in vivo pharmacokinetic profiles and medication-like duration of action in rats.
Orally administered BTRX-335140 (CYM-53093) showed robust efficacy in antagonizing KOR agonist-induced prolactin secretion and in tail-flick analgesia in mice.
| Molecular Weight | 453.55 |
| Formula | C25H32FN5O2 |
| CAS Number | 2244614-14-8 |
| Solubility (25°C) | DMSO ≥ 10 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related Opioid Receptor Products |
|---|
| ADL5859 Hydrochloride
ADL5859 is a potent, selective and orally bioavailable δ-opioid receptor agonist (Ki = 0.84 nM, EC50 = 20 nM). |
| JTC-801
JTC-801 is a novel opioid receptor-like1 (ORL1) receptor antagonist with IC50 of 94 nM. |
| Meptazinol hydrochloride
Meptazinol is a unique centrally active opioid analgesic, which inhibits [3H]dihydromorphine binding with IC50 of 58 nM. |
| Nalmefene hydrochloride
Nalmefene is an opioid receptor antagonist, it is used primarily in the management of alcohol dependence. |
| Naloxone hydrochloride
Naloxone hydrochloride is an opioid inverse agonist compound used to counter the effects of opiate overdose. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
